Perspective from Courtney Kraus, MD
November 15, 2019
2 min read

FDA approves MiSight contact lens to slow myopia progression in children

Perspective from Courtney Kraus, MD
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

The first contact lens indicated to slow myopia progression in children aged 8 to 12 years has received FDA approval, according to an FDA press release.

The MiSight contact lens (CooperVision) is a disposable, soft lens that is limited for one-time use and is not for wearing overnight, the release stated.

The effectiveness and safety of the lens was tested during a 3-year randomized controlled clinical study consisting of 135 children aged 8 to 12 years compared with a conventional soft contact lens. The results of the study showed that myopia was decreased with the MiSight lens compared with a conventional lens.

“Today’s approval is the first FDA-approved product to slow the progression of myopia in children, which ultimately could mean a reduced risk of developing other eye problems,” Malvina Eydelman, MD, director of the division of ophthalmic, and ear, nose and throat devices in the FDA’s Center for Devices and Radiological Health, said in the release.